Bain Capital Public Equity Management’s AbbVie ABBV Stock Holding History

Bain Capital Public Equity Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,588,831	Closed	-$94.1M	–	35
2015 Q4	$94.1M	Sell	1,588,831 -1,410,510	-47%	-$81.2M	2.7%	17
2015 Q3	$163M	Sell	2,999,341 -945,773	-24%	-$61.6M	4.87%	7
2015 Q2	$265M	Buy	3,945,114 +947,847	+32%	+$61.9M	6.88%	3
2015 Q1	$175M	Buy	2,997,267 +546,845	+22%	+$33M	4.36%	8
2014 Q4	$160M	Buy	2,450,422 +983,822	+67%	+$62M	4.01%	7
2014 Q3	$84.7M	Sell	1,466,600 -395,100	-21%	-$21.9M	2.17%	20
2014 Q2	$105M	Buy	+1,861,700	New	+$97.7M	2.55%	14

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bain Capital Public Equity Management's ABBV Position: Q1 2016 in Review

Bain Capital Public Equity Management sold out of AbbVie (ABBV) in Q1 2016, closing a stake of 1,588,831 shares — an estimated $94.1M sold.

Bain Capital Public Equity Management first reported a position in ABBV in Q2 2014 and held it in 7 quarters. The position peaked at $265M in Q2 2015. 1,639 funds tracked by Wall St. Rank hold ABBV as of Q1 2016.

Bain Capital Public Equity Management reported no remaining AbbVie position as of Q1 2016 after selling out during the quarter.
Bain Capital Public Equity Management sold 1,588,831 AbbVie shares in Q1 2016, an estimated $94.1M.
Bain Capital Public Equity Management first reported a position in AbbVie in Q2 2014 and held it in 7 quarters.
Bain Capital Public Equity Management's AbbVie position peaked at $265M in Q2 2015.
1,639 funds tracked by Wall St. Rank held AbbVie as of Q1 2016.

Based on Bain Capital Public Equity Management's 13F filing for Q1 2016, filed 16 May 2016.